280 results
DEFA14A
RGEN
Repligen Corp.
1 Apr 24
Additional proxy soliciting materials
4:21pm
of the selection of Ernst & Young LLP as Repligen Corporation’s independent registered public accounting firm for the fiscal year ending December 31, 2024
8-K
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
(the “Effective Date”). The Board determined that Ms. Pax is independent under the listing standards of the Nasdaq Stock Market.
Pursuant to the terms
8-K
EX-99.1
RGEN
Repligen Corp.
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
, an MIT startup company that was acquired by Daré Bioscience.
Ms. Pax is currently an independent board director for Alimera Sciences, a Nasdaq-listed
8-K
EX-4.1
jv2a88g37r29
15 Dec 23
Entry into a Material Definitive Agreement
4:33pm
8-K
EX-99.1
p71ybe5n6xtuyhqxa
7 Dec 23
Unregistered Sales of Equity Securities
7:39am
8-K
EX-99.1
pptkob
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
EX-99.2
nz6ga77
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
8-K
5xanbfnj
22 May 23
Amendments to Articles of Incorporation or Bylaws
9:28am
8-K
EX-99.1
pdk3gje 1bejlpm8xml
12 Apr 23
Regulation FD Disclosure
7:31am